K Pota

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

NURSING PHARMACOLOGY SHEET

Name of Patient: H. ALTARES


Age & Sex: 73 yrs old/ Female
Principal Diagnosis: HPN Urgency, Chronic CVD Infarct
Allergy: None
C/c: Dyspnea and Decrease I & O

NAME OF DRUG GENERAL SPECIFIC INDICATION CONTRA- ADVERSE EFFECTS NURSING RESPONSIBILITIES
ACTION ACTION INDICATION
K citrate Mineral and Maintain Managem Hyperkalaemi CNS: confusion, 1.Assess for signs and symptoms of
electrolyte acid-base ent of a; severe restlessness, hyperkalemia andhypokalemia.
replacemen balance, dyslipidem renal weakness 2. Monitor pulse,BP,and ECG periodically
t isotonicity, ia impairement; CV: arrythmias, DURING IV therapy.
and including untreated ECG changes 3.Monitor serum potassium before and
electrophy primary Addisons GI: abdominal periodically during therapy. Monitor renal
siologic hyperchol disease; pain, diarrhea, function, serum bicarbonate, and ph.
balance of esterolemi severe tissue flatulence, N&V Determine serum magnesium level if patient
the cell. a, trauma; NEURO: has refractory hypokalemia; hypomagnesemia
Activator in homozygo hyperkalemic paralysis, should be corrected to facilitate effectiveness
many us familial familial paresthesia of potassium replacement
enzymatic cholestero periodic Instruct patient to avoid salt substitutes or low
reactions; lemia and paralysis salt milk or food unless approved by health
essential to homozygo care professional.
transmissio us 4. Assess for symptoms of hyperkalemia
n of nerve sitosterole toxicity.
impulses; mia 5.Emphasize correct method of
contraction administration. GI irritation or ulceration may
of cardiac, result from chewing-enteric coated tablets or
skeletal, insufficient dilution of liquid or powder forms.
smooth 6.Instruct patient to avoid salt substitutes or
muscle; low salt milk or food unless approved by
gastric health care professional. Patient should be
secretion; advised to read all labels to prevent excess
renal potassium intake.
function; 7.Instruct patient to report dark, tarry, or
tissue bloody stools; weakness; unusual fatigue; or
synthesis; tingling of extremities.
and 8.Emphasize the importance of regular follow-
carbohydra up exams to monitor serum levels and
te progress.
metabolis
m

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy